These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 109501

  • 1. Antibody responses of burned patients immunized with a polyvalent Pseudomonas vaccine.
    Jones RJ.
    J Hyg (Lond); 1979 Jun; 82(3):453-62. PubMed ID: 109501
    [Abstract] [Full Text] [Related]

  • 2. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D, Serafińska D, Rudowski W, Hoffman S, Olański W, Gardzińska E, Popiel D, Jedrzejczak G, Czarnecka I.
    Pol Tyg Lek; 1979 Jun; 44(43-45):924-7. PubMed ID: 2518666
    [Abstract] [Full Text] [Related]

  • 3. Controlled trials of a polyvalent pseudomonas vaccine in burns.
    Jones RJ, Roe EA, Gupta JL.
    Lancet; 1979 Nov 10; 2(8150):977-82. PubMed ID: 91774
    [Abstract] [Full Text] [Related]

  • 4. Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent Pseudomonas vaccine.
    Jones RJ, Roe EA.
    Br J Exp Pathol; 1975 Feb 10; 56(1):34-43. PubMed ID: 812544
    [Abstract] [Full Text] [Related]

  • 5. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients].
    Nasiłowski W, Zietkiewicz W, Brudzyńska-Charewicz S, Bukowska D, Serafińska D, Rudowski W.
    Pol Tyg Lek; 1984 Apr 23; 39(17):557-61. PubMed ID: 6435103
    [No Abstract] [Full Text] [Related]

  • 6. [Use of polyvalent vaccine against Pseudomonas aeruginosa in extensive burns].
    Nasiłowski W, Zietkiewicz W, Brudzyńska-Charewicz S, Bukowska D, Serafińska D, Rudowski W.
    Pol Tyg Lek; 1981 Aug 10; 36(32):1207-11. PubMed ID: 6798556
    [No Abstract] [Full Text] [Related]

  • 7. Low mortality in burned patients in a Pseudomonas vaccine trial.
    Jones RJ, Roe EA, Gupta JL.
    Lancet; 1978 Aug 19; 2(8086):401-3. PubMed ID: 79764
    [Abstract] [Full Text] [Related]

  • 8. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
    Lee NG, Jung SB, Ahn BY, Kim YH, Kim JJ, Kim DK, Kim IS, Yoon SM, Nam SW, Kim HS, Park WJ.
    Vaccine; 2000 Mar 17; 18(18):1952-61. PubMed ID: 10699346
    [Abstract] [Full Text] [Related]

  • 9. Enzyme-linked immunosorbent assay (ELISA) and a passive haemagglutination test (PHT) for the detection of pseudomonas antibodies in burned patients.
    Roe EA, Jones RJ.
    Burns Incl Therm Inj; 1985 Apr 17; 11(4):252-8. PubMed ID: 3924353
    [Abstract] [Full Text] [Related]

  • 10. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
    Ionescu A, Meitert E, Vasiliu S, Meitert T, Milicescu S, Sima F, Savulian C.
    Arch Roum Pathol Exp Microbiol; 1979 Apr 17; 38(3-4):317-30. PubMed ID: 122594
    [No Abstract] [Full Text] [Related]

  • 11. Active and passive immunization against Pseudomonas aeruginosa infection of burned patients.
    Roe EA, Jones RJ.
    Burns Incl Therm Inj; 1983 Jul 17; 9(6):433-9. PubMed ID: 6412970
    [Abstract] [Full Text] [Related]

  • 12. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.
    Matthews-Greer JM, Gilleland HE.
    J Infect Dis; 1987 Jun 17; 155(6):1282-91. PubMed ID: 3033095
    [Abstract] [Full Text] [Related]

  • 13. Pseudomonas aeruginosa: prevention better than cure?
    Mellor JA, Miler JJ.
    Dev Biol Stand; 1979 Jun 17; 43():53-9. PubMed ID: 118071
    [Abstract] [Full Text] [Related]

  • 14. Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients.
    Jones RJ, Roe EA, Gupta JL.
    Lancet; 1980 Dec 13; 2(8207):1263-5. PubMed ID: 6108445
    [Abstract] [Full Text] [Related]

  • 15. Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis.
    Zuercher AW, Horn MP, Que JU, Ruedeberg A, Schoeni MH, Schaad UB, Marcus P, Lang AB.
    FEMS Immunol Med Microbiol; 2006 Jul 13; 47(2):302-8. PubMed ID: 16831219
    [Abstract] [Full Text] [Related]

  • 16. [Immunogenic properties of a polyvalent vaccine against Pseudomonas aeruginosa].
    Serafińska D, Bukowska D, Sokołowska K, Nasiłowski W.
    Pol Tyg Lek; 1980 Jul 07; 35(27):1013-5. PubMed ID: 6775310
    [No Abstract] [Full Text] [Related]

  • 17. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S, Safarloo M, Amirmozafari N, Nikokar I, Siadat SD, Holder IA, Mahdavi M.
    APMIS; 2014 Feb 07; 122(2):115-27. PubMed ID: 23758581
    [Abstract] [Full Text] [Related]

  • 18. [Polish preparations for preventing and treating infections caused by Pseudomonas aeruginosa].
    Schiller B, Buchowicz I, Lysakowska E, Sakiel S, Korbecki M.
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr 07; (4):30-2. PubMed ID: 2409720
    [Abstract] [Full Text] [Related]

  • 19. Serological failure of Pseudomonas vaccination in patients receiving multiple chemotherapy.
    Bannister P, Mellor J.
    J Biol Stand; 1985 Oct 07; 13(4):321-6. PubMed ID: 3932361
    [Abstract] [Full Text] [Related]

  • 20. Pseudomonas aeruginosa ribosomal vaccine. A comparison of the immunogenicity of vaccines from two different serotypes.
    Lieberman MM.
    Antibiot Chemother (1971); 1989 Oct 07; 42():193-202. PubMed ID: 2512837
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.